Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cardiotoxicity × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Meningioma 3 Brain Neoplasms 3 Sarcoma 2 Radiation Injuries 2 Prostatic Neoplasms 2 Pituitary Neoplasms 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Esophageal Neoplasms 2 Wilms Tumor 1 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Resectable Lung Non-Small Cell Carcinoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neurofibrosarcoma 1 Neurilemmoma 1 Neoplasms, Adipose Tissue 1 Nasopharyngeal Carcinoma 1 Myoepithelioma 1 Malignant Brain Glioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1

Interventions

Echocardiography 4 Exercise 2 Electrocardiography 2 sulforaphane 1 schizandrin 1 sacubitril and valsartan sodium hydrate drug combination 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 fructus schizandrae, radix ginseng, radix ophiopogonis drug combination 1 empagliflozin 1 dapagliflozin 1 Watchful Waiting 1 Vincristine 1 Tablets 1 Rituximab 1 Proton Therapy 1 Proteins 1 Prednisolone 1 Observation 1 Medical History Taking 1 Lenalidomide 1 Laser-Doppler Flowmetry 1 Environmental Biomarkers 1 Echocardiography, Stress 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Clinical Laboratory Techniques 1 Carvedilol 1 Blood Pressure Determination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡